Allergan's Bid For New Trial Rejected In Zymar Case

Law360, New York (November 4, 2010, 1:27 PM EDT) -- A federal judge has denied Allergan Inc. and other plaintiffs' bid for a new trial concerning the validity of one of the claims of a patent they asserted against Apotex Inc. in a suit over the generic-drug maker's attempt to horn in on the market for pinkeye treatment Zymar.

Judge Sue L. Robinson of the U.S. District Court for the District of Delaware issued a memorandum order Wednesday denying without prejudice a motion filed by Allergan, Senju Pharmaceutical Co. Ltd. and Kyorin Pharmaceutical Co. Ltd. requesting...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.